These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Functional expression and biophysical properties of polymorphic variants of the human gap junction protein connexin37. Kumari SS, Varadaraj K, Valiunas V, Ramanan SV, Christensen EA, Beyer EC, Brink PR. Biochem Biophys Res Commun; 2000 Jul 21; 274(1):216-24. PubMed ID: 10903921 [Abstract] [Full Text] [Related]
6. Site-directed mutations in the transmembrane domain M3 of human connexin37 alter channel conductance and gating. Kumari SS, Varadaraj K, Valiunas V, Brink PR. Biochem Biophys Res Commun; 2001 Jan 19; 280(2):440-7. PubMed ID: 11162536 [Abstract] [Full Text] [Related]
11. Functional expression and biochemical characterization of an epitope-tagged connexin37. Larson DM, Seul KH, Berthoud VM, Lau AF, Sagar GD, Beyer EC. Mol Cell Biol Res Commun; 2000 Feb 23; 3(2):115-21. PubMed ID: 10775509 [Abstract] [Full Text] [Related]
13. Pitfalls when examining gap junction hemichannels: interference from volume-regulated anion channels. Bader P, Weingart R. Pflugers Arch; 2006 Jul 23; 452(4):396-406. PubMed ID: 16604368 [Abstract] [Full Text] [Related]
14. Connexin30 mutations responsible for hidrotic ectodermal dysplasia cause abnormal hemichannel activity. Essenfelder GM, Bruzzone R, Lamartine J, Charollais A, Blanchet-Bardon C, Barbe MT, Meda P, Waksman G. Hum Mol Genet; 2004 Aug 15; 13(16):1703-14. PubMed ID: 15213106 [Abstract] [Full Text] [Related]
15. Possible participation of chloride ion channels in ATP release from cancer cells in suspension. Nejime N, Kagota S, Tada Y, Nakamura K, Hashimoto M, Kunitomo M, Shinozuka K. Clin Exp Pharmacol Physiol; 2009 Mar 15; 36(3):278-82. PubMed ID: 18986334 [Abstract] [Full Text] [Related]